Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 5, 2021
Hormone exposure and its suppressive effect on risk of high-grade gliomas among patients with breast cancerCarlos A Lopez-Garcia, Victor Lopez-Rivera, Antonio Dono, et al.Neurosurgery|June 26, 2024
Validation and Comparison of Common Thoracolumbar Injury Classification Treatment Algorithms and a Novel ModificationJoseph Withrow, Duncan Trimble, Analisa Narro, et al.JCO Clinical Cancer Informatics|April 5, 2023
Prediction of Brain Metastases Development in Patients With Lung Cancer by Explainable Artificial Intelligence From Electronic Health RecordsZhao Li, Rongbin Li, Yujia Zhou, et al.The Neuroradiology Journal|August 3, 2025
IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation statusKamand Khalaj, Elham Tavakkol, Luis Nunez, et al.Clinical Neurology and Neurosurgery|December 23, 2023
Survival outcomes and prognostic factors of infratentorial glioblastoma in the elderlyAnkush Chandra, Victor Lopez-Rivera, Bryan Ryba, et al.Journal of Neuro-Oncology|February 13, 2024
Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtypeAntonio Dono, Jose Torres, Luis Nunez, et al.Journal of Neuro-Oncology|October 3, 2020
Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnosesAntonio Dono, Jennifer Vu, Molly Anapolsky, et al.World Neurosurgery|November 10, 2020
Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?Ankush Chandra, Victor Lopez-Rivera, Antonio Dono, et al.Journal of Neuropathology and Experimental Neurology|April 18, 2025
MTAP immunohistochemistry as a surrogate marker of CDKN2A loss in brain tumors: A meta-analysis and literature reviewAntonio Dono, Diego Pichardo-Rojas, Leonardo Mendoza Mora, et al.Cancers|October 16, 2024
MTAP and p16 IHC as Markers for CDKN2A/B Loss in MeningiomasHanim I Ozkizilkaya, Anjali Vinocha, Antonio Dono, et al.Pageof 8